2024-017 Problems Notes Costs
Admission date2024-03-20
Final date -
Days in captivity51
SpeciesBDOW - Barred owl
AgeATY
SexUNK
StatusReh
Band
Fracture - metacarpus, right
Fracture, metacarpus, open
Ocular - blind, OD
Ocular - cataract, OD
Ocular - Evisceration, OD
Ocular - phthisis bulbi - OD
Ocular - uveitis, OD

Cause of injury: Collision - Vehicle, suspected

Found in Birmingham,AL
Jefferson county
Here is a summary of this patient's treatments and expenses:

Desc Qty Cost Subtotal
Examination175.0075.00
Daily rate5120.001020.00
Radiographs587.75438.75
Physical therapy734.22239.54
Surgery, minor1200.00200.00
Complete blood count158.0058.00
Packed cell volume18.078.07
Blood chemistry145.3545.35
Lab tests1Variable40.00
Total  2124.71

Costs are estimates based on fees charged at a local avian specialist.
Radiographs and images

2024-03-26

2024-03-26

2024-03-26

2024-04-18

2024-04-18

2024-04-22
2024-05-09 15:27 BT

Food: 20 g.
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ (PT days only)
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.55 ml (1.5 mg/ml soln) PO
PT: PROM Right wing - under anesthesia

2024-05-09 14:57 RE

Updated medication doses based on a latest weight of 821 g

2024-05-09 11:10 re

------------- LASER THERAPY ----------------
Power (joules): 504
Time: 5:36
Location: right metacarpal region

2024-05-09 10:15 BT

Food: 20 g
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ (PT days only)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO
PT: PROM Right wing - under anesthesia

2024-05-08 15:10 BT

Food: 20g M, Ch PUT MEDS IN FOOD
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-05-08 09:13 BT
Weight: 821 grams
+12 g(1%)

Food: 20g M, Ch PUT MEDS IN FOOD
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

Feces/urates/pellet present

2024-05-07 16:12 JB

Food: 20g M, PUT MEDS IN FOOD
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-05-07 09:40 SAK

Food: 20g M, Ch PUT MEDS IN FOOD
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

Feces/urates/pellet present

2024-05-06 16:34 re

41g m, ch
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO
PT: PROM Right wing - under anesthesia

2024-05-06 13:24 SO

Figure 8 removed, firm callus on ventral aspect of metacaprus with mild instaility noted. Suture still present. Laser therapy performed. ROM normal, figure 8 wrap replaced.

2024-05-06 11:48 SAK

======= TREATMENT PLAN =======
NPO
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ on 2024-05-13, 2024-05-16, 2024-05-09
(PT days only)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) BID PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) BID PO
PT: PROM Right wing - under anesthesia
==============================
Update PT/NPO/Bup days

2024-05-06 10:27 re

NPO
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ (PT days only)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

BAR, one pellet, normal mutes

2024-05-05 16:11 BT

Food: 24g M, Ch PUT MEDS IN FOOD
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-05-05 08:52 CG

Food: 20g M, Ch PUT MEDS IN FOOD
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

BAR
Ate well
left pellet

2024-05-04 15:25 CG

Food: 20g M, Ch PUT MEDS IN FOOD
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-05-04 09:06 BT

Food: 20g M, Ch PUT MEDS IN FOOD
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-05-03 15:26 BT

Food: 22g M, Ch PUT MEDS IN FOOD
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-05-03 09:35 AMS

======= TREATMENT PLAN =======
Food: 20g M, Ch BID PUT MEDS IN FOOD
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ on 2024-05-13, 2024-05-16, 2024-05-06,
2024-05-09 (PT days only)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) BID PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) BID PO
==============================
d/c TMS

2024-05-03 09:09 CG

Left eye
Anterior chamber: normal
Cornea: normal
Lens: normal
Iris: normal
Fundus: pigment clumping at base of pecten

Diagnosis/recommendations: Eviscerated OD, Normal OS
No recheck needed unless concerns

Eye exam
Exam date - 2024-05-03
Examiner - CG
RIGHTLEFT
PLRMenacePLRMenace
DNEDNE+DNE
Stain Stain 
DNE NEG 
Right eye:
Left eye:
Palpebral reflex: + Dazzle: + Photopic: FN Blepharospasm: - Discharge: - Conj. hyperemia: - Chemosis: - Episcleral inj.: - Ocular position: normal Ocular mobility: normal
2024-05-03 08:12 SAK

======= TREATMENT PLAN =======
Food: 20g M, Ch BID PUT MEDS IN FOOD
TMS: 0.90 ml (48 mg/ml) BID PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ on 2024-05-13, 2024-05-16, 2024-05-06,
2024-05-09 (PT days only)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) BID PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) BID PO
==============================
Update PT and Bup

2024-05-02 15:46 BT

Food: 40 g m
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-05-02 15:12 CG

PT
Induced and maintained on isoflurane.
Wing wrap was removed along with tegaderm patch.
Surgery site looked good. No signs of dehiscence or discharge.
The wing was placed through passive range of motion and massaged for approximately 5 min.
The fracture felt stable.
Cast padding was placed over the fracture site and the wing was wrapped in a figure 8 pattern with vetwrap.
Recovered from anesthesia smoothly and encountered no complications.

Physical therapy
Limb/jointRight wing
TypePROM
 ElbowWrist
Before  
After150180
2024-05-02 08:34 CG

NPO
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ (PT days only)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

BAR
ate well
left pellet
wing wrap intact

2024-05-01 15:25 CG

Food: 20g M, Ch PUT MEDS IN FOOD
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-05-01 09:21 CG
Weight: 809 grams
Food: 18g M, Ch PUT MEDS IN FOOD
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

BAR
Did not eat 27g
Left pellet
Bandage intact

7% decrease in weight

2024-04-30 16:43 re

Food: 21g M, Ch PUT MEDS IN FOOD
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ (PT days only)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-04-30 08:54 CG

Food: 20g M, Ch PUT MEDS IN FOOD
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

BAR
Left Pellet
DNE 1 mouse head; otherwise ate well
Bandage intact

2024-04-29 16:30 SAK

Food: 41g M
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-04-29 14:19 SO

Briefly anesthetized with isoflurane via facemask. Removed figure 8 wrap and bandage. Previous debridement site looks good, no discharge and sutures in place. ROM normal for carpus and elbow and no instability noted at metacarpal fracture. Bandage and figure 8 wrap replaced, splint not replaced. Patient recovered uneventfully

2024-04-29 08:57 CG

NPO
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ (PT days only)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

BAR
Ate Well
Bandage still intact

2024-04-28 15:52 BT

Food: 20g M, Ch PUT MEDS IN FOOD
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-04-28 09:36 BT

Food: 22g M, Ch PUT MEDS IN FOOD
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-04-27 15:38 BT

Food: 20g M, Ch PUT MEDS IN FOOD
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-04-27 10:00 BT

Food: 23g M, Ch PUT MEDS IN FOOD
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ (PT days only)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-04-26 16:17 BT

Food: 20g M, Ch PUT MEDS IN FOOD
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)

Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-04-26 11:00 CG

Food: 21g M, Ch PUT MEDS IN FOOD
TMS: 0.90 ml (48 mg/ml) PO
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

BAR
Did not eat 13 grams
Left Pellet

2024-04-26 10:19 re

======= TREATMENT PLAN =======
Food: 20g M, Ch BID PUT MEDS IN FOOD
TMS: 0.90 ml (48 mg/ml) BID PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SID SQ (PT days only)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) BID PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) BID PO
==============================

2024-04-25 16:37 CG

Food: 40g, M, Ch, Q
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-04-25 16:30 CG

Induced and maintained on isoflurane and heart rate and respiratory rate were monitored for the duration of the procedure.
No anesthetic complications were encountered.

Removed bandage. There was exposed bone at the site of the wound. The exposed portion was debrided with bone rongeurs. Two simple interrupted sutures of 5-0 PDS were placed to close the wound. Minimal blood loss during the procedure.
PROM was performed
The wound was then covered by a telfa pad, tegaderm, and foam tape.
A Sam splint was affixed with silk tape and the wing was wrapped in vetrap in a figure 8 pattern.
CG/AMS

Physical therapy
Limb/jointRight wing
TypePROM
 ElbowWrist
Before  
After150170
2024-04-25 10:07 CG

NPO
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-04-25 09:25 re

======= TREATMENT PLAN =======
NPO
TMS: 0.90 ml (48 mg/ml) BID PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SID SQ
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) BID PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) BID PO
PT: PROM Right wing - under anesthesia
==============================

2024-04-24 16:12 BT

Food: 21g M, Ch
TMS: 0.90 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) PO

2024-04-24 11:46 SAK

======= TREATMENT PLAN =======
Food: 20g M, Ch BID
TMS: 0.90 ml (48 mg/ml) BID PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SID SQ
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) BID PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) BID PO
==============================
Bup to PT days only

2024-04-24 11:35 SAK

======= TREATMENT PLAN =======
Food: 20g M, Ch BID
TMS: 0.90 ml (48 mg/ml) BID PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SID SQ
Gabapentin Oral Susp 15 mg per kg: 0.13 ml (100mg/ml) BID PO
Meloxicam: 0.58 ml (1.5 mg/ml soln) BID PO
==============================
Decreased food amount.

2024-04-24 09:45 BT

Updated medication doses based on a latest weight of 868 g

2024-04-24 08:34 CG
Weight: 868 grams
Food: 30g M, Ch
TMS: 0.87 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.56 ml (1.5 mg/ml soln) PO

BAR
Left Pellet
Did not eat 16g
Weight gain 4% BW

2024-04-23 15:40 CG

Food: 34g M, Ch
TMS: 0.87 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.56 ml (1.5 mg/ml soln) PO

2024-04-23 10:00 CG

Food: 30g M, Ch
TMS: 0.87 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.56 ml (1.5 mg/ml soln) PO

BAR
Left pellet
Ate well
Bandage was slipping off wing.
Removed bandage and replaced with cast padding and vetwrap placed in a figure eight pattern

2024-04-22 16:51 SAK

Food: 59g M, CH
TMS: 0.87 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.56 ml (1.5 mg/ml soln) PO

2024-04-22 13:34 CG

Removed previously placed suture at the site of the wound on the right metacarpus.
Bone was still exposed at the wound.
The wound was cleaned with iodine solution and omnicide was applied.
A duoderm patch was placed on the wound, cast padding was then placed in a figure 8 pattern, then the right wing was wrapped in a figure 8 pattern with vet wrap.
Plan to debride the exposed bone at next PT day.

Physical therapy
Limb/jointRight wing
TypePROM
 ElbowWrist
Before  
After  
Notes
Removed suture. Bone is still exposed at the fracture sight at the right metacarpus. Wound was washed with iodine solution, then applied omnicide. Wound was covered with a duoderm patch and the right wing was wrapped in a figure 8 pattern.
2024-04-22 09:00 CG

NPO
Buprenorphine: 0.05ml (1.8mg/ml) SQ

2024-04-21 16:21 MM

Food: 30g M, Ch
TMS: 0.87 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.56 ml (1.5 mg/ml soln) PO

2024-04-21 10:42 MM

Food: 30g M, Ch
TMS: 0.87 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.56 ml (1.5 mg/ml soln) PO
BAR, ate well, left pellet

2024-04-20 15:33 MM

Food: 31g M
TMS: 0.87 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.56 ml (1.5 mg/ml soln) PO

2024-04-20 10:09 MM

Food: 29g M, Ch
TMS: 0.87 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.56 ml (1.5 mg/ml soln) PO
BAR, ate well, left pellet.

2024-04-19 16:41 AN

Food: 29g M, Ch

2024-04-19 16:03 CG

Food: 30g M, Ch
TMS: 0.87ml (48mg/ml) PO
Buprenorphine SR: 0.05ml (1.8mg/ml) SQ
Gabapentin: 0.12ml (100mg/ml) PO
Meloxicam: 0.56ml (1.5mg/ml soln) PO

2024-04-19 10:50 SAK

======= TREATMENT PLAN =======
Food: 30g M, Ch BID
TMS: 0.87 ml (48 mg/ml) BID PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SID SQ
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) BID PO
Meloxicam: 0.56 ml (1.5 mg/ml soln) BID PO
==============================
D/C Ketorolac, Updated PT/NPO Days

2024-04-19 09:04 CG

Food: 30g M, Ch
TMS: 0.87ml (48mg/ml) PO
Gabapentin: 0.12ml (100mg/ml) PO
Meloxicam: 0.56ml (1.5mg/ml soln) PO
Buprenorphine: 0.05ml (1.8mg/ml) SQ

BAR
Left pellet

2024-04-18 16:44 re

Surgery report
Procedure - Evisceration
Performed by - Czepiel
Surgery time - 0 minutes

Surgery: Evisceration OD

The patient was positioned in dorsal recumbency. The periocular
feathers around the right eye were plucked, and the right eye
and surrounding skin were then prepped in standard fashion with
dilute Betadine and eye wash solution. Proparacaine was not available.
A hemostat was placed to crush the tissue at the lateral canthus,
and then Stevens tenotomy scissors were used to create a lateral
canthotomy. A stab incision was made in the perilimbal cornea
with a 65-Beaver blade, and the entire cornea was then removed
by sharply dissecting it from the limbus using curved Wescott
tenotomy scissors. The uveal and retinal tissue was then bluntly
dissected from the sclera using a cyclodialysis spatula, and
the lens and vitreous were removed with cotton-tipped applicators.
The scleral shell was then copiously flushed twice with dilute
Betadine. No remaining intraocular structures were observed,
and the scleral wall was found to be unremarkable. Some of the
ventral palpebral conjunctiva was removed with Wescott tenotomy
scissors, but no attempt was made to ensure complete removal
of the conjunctival tissues. The eyelid margins were excised
with Stevens tenotomy scissors. Closure was performed in two
layers using 5-0 Vicryl in a simple continuous pattern in the
SQ and an intradermal pattern in the skin. No complications occurred
intraoperatively. 

Surgeon: Czepiel
2024-04-18 16:38 SAK

Food: 61g M, CH
TMS: 0.87 ml (48 mg/ml) PO (Ask about discontinuing on 4-21-24)
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.56 ml (1.5 mg/ml soln) PO

2024-04-18 16:00 CG

Radiography report:
Major metacarpal bone showed some evidence of remodeling. The proximal fragment of the major metacarpal is cranio-laterally displaced.
Minor metacarpal bone showed little to no evidence of remodeling. The proximal fragment of the minor metacarpal is cranio-medially displaced.
Re-check rads to be performed in 4-6 weeks.

2024-04-18 11:12 BE

Ketorolac - OD -

2024-04-18 10:13 CG

NPO
TMS: 0.84ml (48mg/ml) PO
Gabapentin: 0.12ml (100mg/ml) PO
Meloxicam: 0.54ml (1.5mg/ml) PO
Ketorolac -OD-

2024-04-18 08:31 SAK

Updated medication doses based on a latest weight of 832 g

2024-04-17 16:00 CG

Food: 30g M, Ch
TMS: 0.84ml (48mg/ml) PO
Gabapentin: 0.12ml (100mg/ml) PO
Meloxicam: 0.54ml (1.5mg/ml) PO
Ketorolac -OD-

2024-04-17 08:56 CG
Weight: 832 grams
Food: 30g M, Ch
TMS: 0.84ml (48mg/ml) PO
Buprenorphine: 0.05ml (1.8mg/ml) SQ
Gabapentin: 0.12ml (100mg/ml) PO
Meloxicam: 0.54ml (1.5mg/ml soln) PO
Ketorolac -OD-

BAR
Left Pellet

2024-04-17 08:32 re

======= TREATMENT PLAN =======
Food: 30g M, Ch BID
TMS: 0.84 ml (48 mg/ml) BID PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SID SQ
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) BID PO
Meloxicam: 0.54 ml (1.5 mg/ml soln) BID PO
Ketorolac - OD TID -
==============================

2024-04-16 16:25 CG

Food: 30g M, Ch
TMS: 0.84ml (48mg/ml) PO
Gabapentin: 0.12ml (100mg/ml) PO
Meloxicam: 0.54ml (1.5mg/ml soln)
Ketorolac -OD-

2024-04-16 11:46 MM

Ketorolac - OD -

2024-04-16 08:55 CG

Food: 30g M, Ch
TMS: 0.84ml (48mg/ml) PO
Buprenorphine: 0.05ml (1.8mg/ml) SQ
Gabapentin: 0.12ml (100mg/ml) PO
Meloxicam: 0.54ml (1.5mg/ml soln)
Ketorolac -OD-

BAR
left pellet

2024-04-15 16:21 CG

Food 60g M, Ch
TMS: 0.84ml (48mg/ml) PO
Gabapentin: 0.12ml (100mg/ml) PO
Meloxicam: 0.54ml (1.5mg/ml soln) PO
Ketorolac - OD -

2024-04-15 15:55 SAK

======= TREATMENT PLAN =======
NPO
TMS: 0.84 ml (48 mg/ml) BID PO (Ask about discontinuing on 4-21-24)
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SID SQ
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) BID PO
Meloxicam: 0.54 ml (1.5 mg/ml soln) BID PO
Ketorolac - OD TID -
PT: PROM Right wing - under anesthesia
==============================

2024-04-15 13:05 CG

Ketorolac - OD -

2024-04-15 11:18 CG

------------- LASER THERAPY ----------------
Power (joules): 504
Time: 5:36
Location: Right Metacarpal Region
Notes: PROM was performed while the patient was conscious at aproximately 11:10am. The elbow's range of motion was 150 degrees post-PROM. The carpus' ROM was 180 degrees. The right metacarpal region was examined and the surgery site looked clean and without infection, sutures were holding up well, and there was a firm fibrous callus palpated with minimal instability. The right metacarpal region was lasered at 504 J for 5 minutes and 36 seconds. Then the splint was replaced and the wing was wrapped in a figure 8 pattern.

Physical therapy
Limb/jointRight wing
TypePROM
 ElbowWrist
Before  
After150180
2024-04-15 09:00 CG

TMS: 0.84ml (48mg/ml)
Buprenorphine: 0.05ml (1.8mg/ml)
Gabapentin: 0.12ml (15mg/kg)
Meloxicam: 0.54ml (1.5mg/ml soln)
Ketorolac - OD -

BAR
Left pellet

2024-04-14 15:57 CG

Food: 30g M, Ch
TMS: 0.84ml (48mg/ml) PO
Gabapentin Oral Susp. 0.12ml (100mg/ml) PO
Ketorolac - OD -

2024-04-14 09:38 CG

Food: 30g M, Ch
TMS: 0.84ml (48mg/ml)
Buprenorphine: 0.05ml (1.8mg/ml)
Gabapentin: 0.12ml (15mg/kg)
Meloxicam: 0.54ml (1.5mg/ml soln)
Ketorolac - OD -

QAR
Left Pellet

2024-04-13 15:37 BE

Food: 29g M
TMS: 0.84 ml (48 mg/ml) PO
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.54 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-04-13 07:54 BE

Food: 28g Ch
TMS: 0.84 ml (48 mg/ml) PO
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.54 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

BAR, ate all food, left one pellet

2024-04-12 15:27 CG

Ketorolac - OD -

2024-04-12 13:24 re

Food: 32g M, Ch
TMS: 0.84 ml (48 mg/ml) PO
Buprenorphine SR Owl: 0.05 ml (1.8mg/ml) SQ
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.54 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

BAR, one pellet

2024-04-11 16:31 BT

FOOD: 60 g m, ch
TMS: 0.84 ml (48 mg/ml) PO
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) PO
Meloxicam: 0.54 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-04-11 14:15 Michelle

Ketorolac - OD -

2024-04-11 08:16 SAK

Updated medication doses based on a latest weight of 811 g

2024-04-10 16:36 CG

Changed Bandage
A previously placed suture had pulled through and the wound had re-opened. Lidocaine was administered and an additional suture was placed to close the wound.
Placed smaller splint and wrapped right wing in a figure 8 pattern.

2024-04-10 16:16 CG

Food: 30g M, Ch
TMS: 0.77ml (48mg/ml) PO
Meloxicam: 0.5ml (1.5mg/ml soln) PO
Ketorolac OD
Gabapentin 0.12ml (100mg/ml soln) PO

2024-04-10 14:55 SAK

======= TREATMENT PLAN =======
Food: 30g M, Ch BID
TMS: 0.77 ml (48 mg/ml) BID PO
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SID SQ
Gabapentin Oral Susp 15 mg per kg: 0.12 ml (100mg/ml) BID PO
Meloxicam: 0.50 ml (1.5 mg/ml soln) BID PO
Ketorolac - OD TID -
==============================
Added gabapentin to treatment

2024-04-10 10:25 re
Weight: 811 grams
Food: 30g M, Ch
TMS: 0.77 ml (48 mg/ml) PO
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.50 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
BAR, pellet
9% weight gain

2024-04-09 18:26 AMS

Surgery report
Procedure - Wound debridement
Performed by -
Surgery time - 20 minutes

The site of the open metacarpal fracture along the ventral R
wing was aseptically prepared with dilute betadine.  The sharp
bone edge was pale grey and of questionable viability. There
was also concern for being able to close the site over this protruding
piece of bone. Therefore, the sharp protruding portion of bone
was debrided with rongeurs and briefly filed with a rasp to smooth
the edges. The surrounding skin was freed/elevated. The wound
was apposed with 5-0 PDS, using catheter tubing to alleviate
skin tension on one of the sutures. Omnicide wound gel was applied
and the area was covered with a tegaderm+pad, SAM splint, and
wing-to-body wrap. AMS
2024-04-09 17:12 SAK

Food: 30g M, Ch
TMS: 0.77 ml (48 mg/ml) PO
Meloxicam: 0.50 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-04-09 14:47 SAK

======= TREATMENT PLAN =======
Food: 30g M, Ch BID
TMS: 0.77 ml (48 mg/ml) BID PO
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SID SQ
Meloxicam: 0.50 ml (1.5 mg/ml soln) BID PO
Ketorolac - OD TID -
==============================
Add TMS to treatment

2024-04-09 09:00 SAK

Food: 30g M, Ch
TMS: 0.77 ml (48 mg/ml) PO
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.50 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-04-08 18:01 CG

------------- LASER THERAPY ----------------
Power (joules): 504
Time: 5min
Location: right metacarpal region
Notes: PROM performed under general anesthesia. 017 was anesthetized using isoflurane. The elbow's range of motion was normal and the carpus' range of motion was approximately 180 degrees after PROM. A firm fibrous callus was palpated in the right metacarpal region. The fracture site was lasered for approximately 5 min and then bandaged in a figure eight pattern. 017's heart rate and respiratory rate were monitored while under general anesthesia. Patient's recovery was smooth.

2024-04-08 16:24 AN

61g M, Ch
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.50 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
PT: PROM Right wing - under anesthesia

2024-04-08 15:53 SAK

placed tail guard, few broken tail feathers noted

2024-04-08 10:25 SAK

NPO
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.50 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
PT: PROM Right wing - under anesthesia
Left Pellet

2024-04-07 15:59 CR

Food: 33g M
Meloxicam: 0.50 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-04-07 12:54 BT


Ketorolac - OD -

2024-04-07 10:21 CR

Food: 33g M & Ch
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.50 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
BAR, upright on perch, clicking, shredding perch, normal mutes, one pellet

2024-04-06 15:52 CR

Food: 30g M
Meloxicam: 0.50 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-04-06 10:53 CR

Food: 30g M
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.50 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
BAR, upright on perch, clacking, normal mutes, 1 pellet, removed SAM splint overnight, replaced SAM splint with cast padding, vet wrap and a body wrap.

2024-04-05 16:35 BT

Food: 29g M, Ch

Meloxicam: 0.50 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

Figure of eight wrap replaced with a body wrap.

2024-04-05 09:51 re

Food: 32g M, Ch
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.50 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

BAR, normal mutes, one pellet

2024-04-05 08:08 SAK

Updated medication doses based on a latest weight of 745 g

2024-04-04 16:57 CR

------------- LASER THERAPY ----------------
Power (joules): 504
Time: 5 min 36 sec
Location: right metacarpal region
PROM performed under anesthesia. 017 was anesthetized with ISO (5%) at 3:11 PM. The elbow was at a normal ROM, while the carpus was at 160 degrees. After brief PROM, the carpus angle improved back to a normal 180 degrees. The right metacarpal region palpated as a firm firbrocallus with minimal to no instability. Fracture site was lasered (504 J) for 5 minutes and then secured with cast padding and vet wrap in a figure of eight pattern. We elected to remove the vetlyte splint in order to prevent any potential pressure necrosis of the fibrocallue's contact with the splint and the figure of eight was elected to prevent 017 from reinjuring it in the cage. HR & RR were monitored with auscultation during the procedure. Under anesthesia for 12 minutes. Patient recovery uneventful.

Physical therapy
Limb/jointRight wing
TypePROM
 ElbowWrist
Before150160
After150180
2024-04-04 16:43 CR

Food: 33g M
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
PT: PROM Right wing - under anesthesia

2024-04-04 13:35 CR

Could not give Ketorolac - OD -, 017 kept jumping on the door trying to escape.

2024-04-04 09:58 CR

NPO
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
PT: PROM Right wing - under anesthesia
BAR, upright on perch, clicking.
Normal mutes, one pellet

2024-04-03 17:00 CR

Food: 33g M
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-04-03 13:34 CR

Ketorolac - OD -

2024-04-03 09:53 CR
Weight: 745 grams
Food: 33g M
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
Weight: 745g +65g (10% of BW)
BAR, upright on perch, clicking, normal mutes, one pellet.
Right eye progressively getting smaller and starting to appear concave.

2024-04-02 16:25 CR

Food: 33g Ch
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-04-02 13:16 CR

Ketorolac - OD -

2024-04-02 09:39 CR

Food: 30g M, Ch
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
BAR, upright on perch, clicking, one pellet, normal mutes

2024-04-01 17:29 CR

PROM performed under anesthesia. 017 preoxygenated with O2 for 1-2 minutes then anesthetized with ISO (5%) at 3:13 PM. Both elbow and carpus are at a normal ROM currently. Right metacarpal region has a firm callus but some instability. Fracture site was lasered (504 J) and then secured with vetlyte, cast padding, and vet wrap in a figure of eight pattern. HR & RR were monitored with auscultation during the procedure. Under anesthesia for 21 minutes. Patient recovery uneventful.
------------- LASER THERAPY ----------------
Power (joules): 504
Location: Right Wing metacarpal region

Physical therapy
Limb/jointRight wing
TypePROM
 ElbowWrist
Before150180
After150180
Notes
PROM performed under anesthesia. Both elbow and carpus are at a normal ROM currently. Fracture site was secured with vetlyte, cast padding, and vet wrap in a figure of eight pattern.
2024-04-01 17:23 CR

Food: 58g M
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO BID
Ketorolac - OD -

2024-04-01 13:05 CR

Ketorolac - OD -

2024-04-01 10:26 CR

NPO
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-04-01 08:42 SAK

======= TREATMENT PLAN =======
NPO
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SID SQ
Meloxicam: 0.46 ml (1.5 mg/ml soln) BID PO
Ketorolac - OD TID -
PT: PROM Right wing - under anesthesia
==============================
Ketorolac to TID

2024-03-31 15:58 Allison

Food: 34g
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-03-31 09:59 Allison

Food: 33g M
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
1 pellet

2024-03-30 15:58 Allison

Food: 31g M
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-03-30 10:26 Allison

Food: 33g M, Ch
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
1 pellet. Leftover from last feeding: 7 g. Left food in cage this AM.

2024-03-29 16:16 BT

Food: 30g M, Ch
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SQ
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-03-29 10:25 AMS

======= TREATMENT PLAN =======
Food: 30g M, Ch BID
Buprenorphine SR Owl: 0.04 ml (1.8mg/ml) SID SQ
Meloxicam: 0.46 ml (1.5 mg/ml soln) BID PO
Ketorolac - OD BID -
==============================
added Bup

2024-03-29 09:27 AN

Food: 30g M, Ch
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
Left pellet and feces

2024-03-28 18:40 CR

Serum chemistry
Collection date2024-03-27
AST393 U/LPhos4.2 mg/dl
BA26 umol/LTP4.7 g/dl
CK1015 U/LAlb0.0 g/dl
UA7.0 mg/dlGlob0.0 g/dl
Glu300 mg/dlK+2.7 mmol/l
Ca10.1 mg/dlNa+147 mmol/l
  AMY259 U/L
Hem 0, Lip 0, Ict 0
CBC
Collection date2024-03-27
WBC count13200
Corrected count13200
Hets/Neut61% - 8052
  Bands0+
  Toxics0+
Lymphs23% - 3036
Eos3% - 396
Mono11% - 1452
Baso2% - 264
Thrombocytes
PI1
HemoproteusNEG
LeukocytozoonNEG
PlasmodiumNEG
Read byUMiami Avian & Wildlife Lab
Elevated heterophil % level (reference interval 10-52%). This correlates with the inflammation present with the right metacarpal fracture. Presence of polychromasia (normal in birds) and reactive monocytes (rare).
2024-03-28 18:12 re

Examined by Dr. Czepiel
Left eye (OS) entry: Normal
PLR +
Palpebral +
Dazzle +
Fluorescein -
IOP 22
No other significant findings.

Right eye (OD) entry: Early phthisis bulbi, uveitis, suspect hypermature cataract, blind
PLR -
Palpebral +
Dazzle -
Fluorescein -
IOP cornea too soft to measure (hypotony)
Uveitis, early phthisis bulbi (smaller eye), suspect a hypermature lens, blind OD.
Deep anterior chamber suspected from the changes in pressure of the eye.
Mydriatic, 3-4+ flare, resolving retinal hemorrhage.


Recommendations: Continue meloxicam and ketorolac OD BID. Consider evisceration OD or increasing ketorolac to TID with a recheck in 2 weeks.

Eye exam
Exam date - 2024-03-28
Examiner - re
RIGHTLEFT
PLRMenacePLRMenace
DNEDNEDNEDNE
Stain Stain 
DNE DNE 
Right eye:
Left eye:
2024-03-28 16:10 AN

61g m
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
PT: PROM Right wing - under anesthesia

2024-03-28 10:38 BT

NPO
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-03-28 10:26 SAK

PROM performed under anesthesia. 017 preoxygenated with O2 for 1-2 minutes then anesthetized with ISO (5%) at 1:34 PM. The elbow began at 140 degrees and the carpus began at 170 degrees. After about 30 seconds of PT the joints returned to a normal ROM. Right metacarpal region has a firm callus but some instability. Fracture site was secured with vetlyte, cast padding, and vet wrap in a figure of eight pattern. HR & RR were monitored with auscultation during the procedure. Under anesthesia for 11 minutes. Patient recovery uneventful.

Physical therapy
Limb/jointRight wing
TypePROM
 ElbowWrist
Before140170
After150180
Notes
Passive range of motion done under anesthesia. Right metacarpal region has a firm callus but some instability. The fracture site was secured using vetlyte, cast padding and vet wrap in a figure of eight bandage. Plan to repeat PT on Monday (April 1st).
2024-03-28 08:30 SAK

======= TREATMENT PLAN =======
NPO
Meloxicam: 0.46 ml (1.5 mg/ml soln) BID PO
Ketorolac - OD BID -
PT: PROM Right wing - under anesthesia
==============================
Update PT/NPO days

2024-03-27 16:43 BT

Food: 29g M
Meloxicam: 0.46 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-03-27 13:34 AMS

Updated medication doses based on a latest weight of 680 g

2024-03-27 11:00 SAK

Drew blood from right jugular, sent to UM for advanced well bird.

PCV/TP
Collection date2024-03-27 11:00:00
PCV39 %
TS5.0 g\dl
Serum
Blood lead
Collection date2024-03-27
Level0.00
2024-03-27 09:52 BT

Food: 29g M
Meloxicam: 0.44 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-03-27 09:18 BT
Weight: 680 grams
+24 (4%)

2024-03-26 17:29 CR

Food: 30g M
Meloxicam: 0.44 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
Normal mutes. Upright on floor of cage. BAR.

2024-03-26 16:40 re

Images taken: Body VD, Right Lateral Wing, Right Extremity Cranial-Caudal Wing
Radiology Interpretation:
Fracture of both metacarpals. Major metacarpal has a closed, comminuted fracture of the diaphysis. Minor metacarpal has a closed, complete, short oblique diaphyseal fracture. No significant osseous callus formation. The fracture is chronic in nature and the fracture margins are ill defined. There are no obvious signs of healing if chronic in nature. Recommended recheck in 3 weeks to monitor healing progression.
Anesthesia Protocol:
017 was anesthetized with isoflurane and was monitored every 2-3 minutes by checking heart rate and respiratory rate. The bird was maintained for a majority of the imaging procedure at 5 for gas anesthesthetic and switched to 4 closer to the end of our procedure. A figure of eight wrap was placed and gas anesthetic was ended. 017 was held in an upright position during recovery until they were able to hold their own head up. Then they were placed in a transport box to be moved back to SERC.

2024-03-26 10:00 CR

Food: 29g M, Ch
Meloxicam: 0.44 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
Normal mutes, one pellet, no left overs.
Urpright in perch, BAR, clicking at me.

2024-03-25 17:39 CR


------------- PHYSICAL EXAM FINDINGS ----------------
Attending Veterinarian: Dr. Amberly Sokoloff
Observational examination
Mentation: BAR
Posture: Upright in back of cage
Vital stats
Eyes: Right eye anterior chamber appears very deep (posterior lens luxation??), retina has one focal white spot surrounded with mild hemorrhage, mydriatic, no PLR
Wings: Right wing, major metacarpal fractured with significant dorsal displacement, possible luxation at the metacarpal/digital joint. SAM splint placed over injured region and secured with a body wrap

Plan: Request rads taken at rDVM, potentially repeat radiographs.

2024-03-25 17:36 CR

Food: 30g M
Meloxicam: 0.44 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-03-25 14:19 CR

Food: 30g M, Ch
Meloxicam: 0.44 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
Mutes normal.
One pellet.
No leftovers.

2024-03-24 16:04 Marissa

Food: 30g M, Ch
Meloxicam: 0.44 ml (1.5 mg/ml soln) PO
Ketorolac - OD - BID

2024-03-24 10:13 Marissa

Food: 31g M, Ch
Meloxicam: 0.44 ml (1.5 mg/ml soln) PO
Ketorolac - OD - BID

pellet in cage

2024-03-23 16:29 Bailynn Peeler

Food: 30g M, Ch
Meloxicam: 0.44 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-03-23 10:17 Bailynn Peeler

Food: 33g M, Ch
Meloxicam: 0.44 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-03-22 16:00 Bailynn Peeler

Food: 33g M, Ch
Meloxicam: 0.44 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2024-03-22 15:57 re

Sample
Collection date2024-03-22
Typechoanal/cloacal swab
Notes:
Results:
AI PCR : Not detected
2024-03-22 09:37 SAK

Food: 30g Ch
Meloxicam: 0.44 ml (1.5 mg/ml soln) PO (in food)
Ketorolac - OD -

No leftovers, pellet, feces, urates present.

2024-03-21 16:33 AN

Food: 30g M, Ch
Meloxicam: 0.44 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
There were no leftovers present in the cage so i placed meds in food and left food in the cage

2024-03-21 09:10 SAK

Food: 25g M
Meloxicam: 0.44 ml (1.5 mg/ml soln) PO - Given orally not in food
Ketorolac - OD -

Swabbed for AI and sent to State Lab

2024-03-21 08:27 SAK

======= TREATMENT PLAN =======
Food: 30g M, Ch BID
Meloxicam: 0.44 ml (1.5 mg/ml soln) BID PO
Ketorolac - OD BID -
==============================

2024-03-20 17:39 Bailynn Peeler
Weight: 656 grams, BCS: 3.0

------------- PHYSICAL EXAM FINDINGS ----------------
Attending Veterinarian: Dr. Seth Oster
Observational examination
Mentation: Bright, alert, and responsive
Posture: Upright
Vital stats
Dehydration: Euhydration
Beak: Normal
Cere/nares: Normal
Eyes: The right eye was non-visual. The left eye had pigment clumping and a good PLR.
Ears: Normal
Wings: Right wing had a palpable metcarpal fracture that was in the beginning stages of healing.
BCS: 3
Problem list: 1. Nonvisual right eye
2. Pigment clumping left eye
3. Fractured right metacarpal
Diagnosis: 1. Nonvisual right eye
2. Pigment clumping left eye
3. Fractured right metacarpal
Assessment: 2024-017 has a fractured right metacarpal bone that has begun to heal based on palpation. The wing was placed in a wing wrap for stabalization. The eyes were also examined and the right eye was completely non-visual. The left eye still had a good PLR but did have pigment clumping present. Further evauluation is need to assess the patient's visual abilities in the left eye.
Plan: 1.Collect HPAI test tomorrow (3/21/2024) and send it to the state lab
2. Rdiograph right wing to see how far along the fracture has healed
3. Schedule ophthamology appointment to assess vision in the left eye.
4. Administer injectable meloxicam 0.13 ml for pain/inflammation
5. Administer Ketoralac to help with inflammation of the eye
Prognosis: Fair

2024-03-20 11:26 SAK

Version 3.1.7 - 3.18.63 Fri May 10 03:00:22 2024